Vaccination of puppies with Eurican: purpose and method of application. Prevention of fatal diseases in dogs: the Eurican vaccine. Instructions for use, side effects Contraindications and side effects for vaccination with Eurican

Eurican is a French-made vaccine that has gained popularity around the world. At the moment, it is one of the most effective means for the prevention of such dangerous canine diseases as: rabies, distemper, parainfluenza, leptospirosis, parvovirus enteritis. The animal develops stable immunity on the 21st day after using the vaccine and lasts for a year.

Description of the drug Eurikan. Its release form and composition

Eurikan is a vaccine consisting of two components - Eurikan DHPPI2 And Eurikan RL. These components are the main active ingredients of this vaccine.

Eurican DHPPI2 is a slightly yellowish powder. These are, in essence, attenuated strains of plague, parainfluenza, adenovirus and parvovirus viruses.

Eurican RL is a clear liquid with a characteristic white precipitate. This liquid consists of inactivated leptospira serogroups Canicola and Icterrohemorrhagia and inactivated rabies virus. On the modern market of veterinary drugs you can also find the Eurikan vaccine, the second component of which is not Eurikan RL, but Eurikan L. The difference between these vaccines is that Eurikan L does not contain an inactivated rabies virus, as a result of which it is not able to protect the animal from rabies virus.

Each vaccine component is packaged in 1 ml glass flasks. in each. To vaccinate an animal, immediately before vaccination, the contents of both flasks are combined by moving the liquid component of the vaccine to the powder component using a sterile syringe and shaken.

Indications for use of Eurikan and instructions

Eurikan is a medical product that does not belong to the medicinal category. It has purely preventive action. It is important to clearly understand that it is unsuitable for the treatment of any dog ​​diseases.

The main indication for the use of Eurican is the absence of vaccinations in the animal against rabies, plague, parainfluenza, leptospirosis, and parvovirus enteritis.

When deciding to vaccinate your pet with Eurican, you should remember a few simple rules:

• First, the animal should be closely monitored for several weeks before vaccination. It wouldn’t hurt to take your four-legged friend to the veterinarian for a routine check-up several times. All this should be done to ensure that the animal is completely healthy.
• Secondly, it is advisable to carry out deworming approximately 12 days before vaccination. Under no circumstances should this procedure be carried out later.
• Thirdly, if you decide to protect your dog from dangerous diseases with the help of Eurican, you should remember that it is very important to follow the vaccination schedule in the future. So the first vaccination with this drug is recommended for an animal at the age of 3 months. The next one is in 4 weeks. Further vaccination is carried out regularly throughout the life of the animal with an interval of 1 year.

A single injection dose is 1 ml. regardless of the age, weight and breed of the dog. It can be administered either subcutaneously or intramuscularly. Consult your veterinarian before use!

Contraindications and side effects from vaccination with Eurican

• Individual hypersensitivity and intolerance to the components of the drug.
• Vaccination of an animal against rabies, plague, parainfluenza, leptospirosis, parvovirus enteritis, etc. with other drugs.
• The dog has helminths.
• The presence of one of the diseases in the animal from which Eurican protects.
• The animal is less than 3 months old.

Side effects after using Eurican occur in a fairly small number of dogs and, as a rule, are expressed in mild swelling in the injection area. Allergic reactions occur much less frequently, however, they are very mild and go away on their own within 24 hours.

INSTRUCTIONS
on the use of the vaccine Eurican DHPPi2-LR (Eurican DHPPi2-LR)

1. General information:

1.1 Trade name: Eurikan DHPPi2-LR ( Eurican DHPPi2-LR)

International nonproprietary name: vaccine against distemper, adenovirus, parvovirus, parainfluenza-2, leptospirosis and canine rabies.

1.2 Dosage form: lyophilized tablet (dry weight – live vaccine Eurikan DHPPI2) and liquid component (inactivated vaccine Eurican–LR) for the preparation of suspension for injection.

Eurikan DHPPI2 made from culture liquids of cell cultures infected with attenuated strains of canine distemper virus, adenovirus CAV 2, parvovirus and canine parainfluenza virus-2 with the addition of polypeptides (22.5 mg/dose) and glucids (77.5 mg/dose) as stabilizers.

Eurican–LR made from a suspension of inactivated leptospira serogroups Leptospira icterohaemorrhagiae and Leptospira canicola, glycoproteins of the rabies virus, ( strain G52), with the addition of aluminum hydroxide (0.6 mg) as an adjuvant.

The lyophilized component of the vaccine in appearance is a dry, homogeneous, porous mass of beige color, the liquid component is a colorless liquid with a white precipitate, which forms a homogeneous suspension when shaken.

Vaccine components Eurikan DHPPi2-LR packaged in 1 immunizing dose (1 ml) in glass bottles of appropriate capacity, hermetically sealed with rubber stoppers reinforced with aluminum caps.

1.3 Vials with the vaccine are packaged in plastic boxes of 10 or 50 immunizing doses.
Each box of vaccine contains instructions for its use.
The shelf life of the vaccine is 24 months from the date of release, subject to storage and transportation conditions. After the expiration date, the vaccine is not suitable for use.

1.4 The vaccine is stored and transported in a dry, dark place at a temperature of 2 to 8C.
The vaccine cannot be frozen.

1.5 The vaccine should be stored out of the reach of children.

1.6 Vials with a vaccine without labels, with an expired expiration date, with a violation of the integrity and/or tightness of the closure, with a changed color and/or consistency of the contents, with the presence of foreign impurities are subject to rejection and disinfection by boiling for 10 minutes.
Disposal of decontaminated vaccine does not require special precautions.

2. Biological properties

2.1 Vaccine Eurikan DHPPi2-LR causes the formation of an immune response in dogs against causative agents of canine distemper, infectious hepatitis, parvovirosis, parainfluenza-2, leptospirosis and rabies 14 days after vaccination, lasting at least 12 months.

One immunizing dose (1 ml) contains at least 104.0 CCID50 of attenuated plague virus; not less than 102.5CCID50 attenuated canine adenovirus ( CAV 2); not less than 104.9CCID50 attenuated canine parvovirus; not less than 104.7CCID50 attenuated canine parainfluenza virus type 2, inactivated Leptospira icterohaemorrhagiae and Leptospira canicola; at least 1 IU of rabies virus glycoproteins ( strain G52).

The vaccine is harmless and has no medicinal properties.

3. Application procedure

3.1 Vaccine Eurican DHPPi2-LR intended for immunization of dogs against distemper, infectious hepatitis, parvovirosis, parainfluenza-2, leptospirosis and rabies.

3.2 It is prohibited to vaccinate clinically sick and/or weakened animals. 10 days before vaccination it is necessary to deworm the dog. Pregnant bitches should be vaccinated in the first third of pregnancy.

3.3 Vaccine Eurikan DHPPi2-LR administered subcutaneously in the area of ​​the shoulder blade, from 12 weeks of age, 3-5 weeks before or after the vaccine DHPPI2–L, in a dose of 1 ml, regardless of the body weight and breed of the dog.
Revaccination is carried out annually at the same dose.

When vaccinating, it is necessary to follow the rules of asepsis and antiseptics. Before vaccination, lyophilized vaccine component Eurikan DHPPI2 combined with liquid component Eurican–LR.
To do this, shake the liquid component of the vaccine and transfer it with a sterile syringe into a bottle with a lyophilized component and mix until completely dissolved. The drug prepared in this way must be used immediately.

3.4 Symptoms of plague, adenovirosis, parvovirosis, parainfluenza-2, leptospirosis and canine rabies or other pathological signs have not been established in case of an overdose of the vaccine.

3.5 Features of the post-vaccination reaction during primary and subsequent immunizations have not been established.

3.6 Violations of the vaccination schedule should be avoided, as this may lead to a decrease in the effectiveness of immunoprophylaxis against distemper, adenovirus, parvovirosis, parainfluenza-2, leptospirosis and rabies in dogs. If the next dose is missed, immunization should be carried out as soon as possible.

3.7 A quickly disappearing swelling may appear at the injection site. If an anaphylactic reaction occurs, treat symptomatically.

3.8 The use of the vaccine is not allowed Eurikan DHPPi2-LR simultaneously with other vaccines and drugs from other groups.

EURICAN DHPPi + LR against canine distemper, parvovirus enteritis, infectious hepatitis, parainfluenza, leptospirosis and canine rabies, MERIAL, France

Description:

Eurican DHPPI2 - LR" - vaccine against distemper, adenovirus, parvovirus, parainfluenza type 2, leptospirosis and rabies in dogs.

General provisions:

1.1. The vaccine against distemper, adenovirus, parvovirosis, parainfluenza, leptospirosis and canine rabies “Eurikan DHPPI2-LR” consists of two components:

Lyophilized vaccine "Eurikan DHPPI2", which is a mixture of attenuated strains of canine distemper virus, adenovirus type 2, parvovirus and canine parainfluenza virus type 2.

The vaccine in appearance is a dry, homogeneous, porous mass of white color - the liquid vaccine "Eurican-LR", containing inactivated rabies virus and inactivated leptospira of the Icterrohemorrhagia and Canicola serogroups.

The vaccine in appearance is a colorless transparent liquid.

1.2. The components of the Eurikan DHPPI2-LR vaccine are packaged in glass bottles of 1 ml (1 dose).

The bottles are sealed with rubber stoppers and rolled with aluminum caps.

Each bottle is equipped with a label indicating: the name of the manufacturer and its trademark, the name of the vaccine, its volume, method of administration, batch number, expiration date.

1.3. The vaccine is packaged in cardboard or plastic boxes: - 100 bottles of the Eurican DHPPI2 and Eurican-LR vaccines or 10 bottles of the Eurican DHPPI2 and Eurican-LR vaccines.

Each box includes instructions on how to use the vaccine.

1.4. A label is applied to the boxes indicating: the name and trademark of the manufacturer, the name of the vaccine, its volume, method of administration, batch number, expiration date.

1.5. The drug is stored at a temperature of 2 to 8 ° C in a dry, dark place.

Under the specified storage conditions, the shelf life of the drug is 24 months from the date of manufacture.

1.6. Vials with broken closures, mold, mechanical impurities, or those that have been frozen are discarded and disinfected by boiling for 10 minutes.

2. Biological properties of the vaccine

2.1. The Eurikan DHPPI2-LR vaccine causes the production of specific antibodies against distemper virus, adenovirus type 2, parvovirus, parainfluenza virus type 2, leptospirosis and rabies in dogs.

2.2. The vaccine is harmless and areactogenic.

2.3. Immunity is formed within 14-21 days. after the 1st vaccination.

Duration of immunity is at least 12 months.

3. Procedure for using the vaccine

3.1. The Eurican DHPPI2-LR vaccine is used to prevent distemper, adenovirus, parvovirus, parainfluenza, leptospirosis and rabies in dogs.

3.2. The vaccine “Eurikan DHPPI2-LR” is used only for healthy animals free of helminths.

3.3. When vaccinating, it is necessary to follow the rules of asepsis and antiseptics and use only sterile materials and instruments for injection.

3.4. Before vaccination, prepare a mixture by mixing the lyophilized vaccine “Eurican DHPPI2” with the liquid vaccine “Eurican-LR”, for which the liquid vaccine is drawn up with a sterile syringe, pierced with a needle, injected into the bottle with the lyophilized vaccine and shaken thoroughly.

It is unlikely that you will meet an owner today who does not know about the need to vaccinate their pets. Hoping for chance can cost a dog not just his health, but also his life. But how to choose one that will be most useful and harmless for the dog? One of the best vaccines these days is called “Eurican” for dogs, produced in France. Let's try to figure out how to properly administer this drug to animals, as well as what its features are.

"DHPPI2-LR"- a vaccine that, like the previous one, combines a dry mixture of strains of adenovirus, parainfluenza, plague, parvovirus and a liquid containing leptospira and rabies glycoproteins. That is, unlike DHPPI2-L, the DHPPI2-LR vaccine also promotes the development of immunity against rabies;

"Piro"- dry vaccine included with a diluent. Helps save dogs from piroplasmosis (babesiosis);

Primo- vaccine in the form of a liquid (suspension). Promotes the development of immunity against parvovirus enteritis.

How and where to administer Eurican to dogs?

The instructions from the Merial company state that it is permissible to administer Primo, the first of the Eurikan vaccines, at the age of 4-6 weeks, revaccination with it is carried out after 6 weeks, and then the drug is re-injected a year later, and then every 2 years. The DHPPI2-L vaccine is injected at 7-8 weeks, and then it’s time for DHPPI2-LR, which is administered to dogs at 12 weeks and once annually. The Piro vaccine is used for puppies at the age of 5 months. Revaccination is carried out at 6 months and then once annually. The manufacturer offers the following vaccination schedule for puppies (before administration, it is necessary to agree on the vaccination schedule with a veterinarian and clarify which vaccine should be preferred and which one should be refused):

1. At 2 months – “DHPPI2-L”;
2. At 3 months – “DHPPI2-LR”;
3. At 5 months – “Piro”;
4. At 6 months – “Piro” (revaccination);
5. After 15 months and then annually once - “DHPPI2-LR”;
6. After 18 months and then annually once - “Piro”.

Before vaccinating a dog, the dry and liquid components of Eurican are mixed with each other, vigorously shaking. The Eurican Primo vaccine is simply shaken, since it is already liquid. Then the animal is given a subcutaneous injection in the scapular area or an intramuscular injection in the hip area (“Primo” is injected subcutaneously in the scapular area). In the case of Eurican Piro, the injection is made subcutaneously in the withers area. It is recommended to treat the injection site with an alcohol solution. If possible, it is advisable to vaccinate under the supervision of a doctor (or have him inject the dog).

In some cases, dogs may develop a slight swelling at the injection site (it goes away on its own within a day or two). An apathetic state is also possible. After “Eurikan Piro”, pets experience increased and very rarely anaphylactic shock (this will require urgent contact with a veterinarian);

Regardless of the dog’s weight, gender, and gender, the vaccine is administered in an amount of 1 dose equal to 1 ml.

What do dog owners think about Eurikan vaccines?

Here are some reviews from owners who used the Eurican vaccine to save their dogs:

Review #1:“We got a puppy. Naturally, we decided to get all vaccinations to exclude infectious diseases. The doctor recommended Eurican. At the time of the injection, the puppy didn’t even make a sound, but by the evening he looked bad: his temperature jumped, he refused to eat, he didn’t even want to drink, he just lay there sad. In the morning I went up to him, he seemed to have eaten a little minced meat, he even barked a couple of times, there was no temperature. That is, there were side effects, albeit short-lived”;

Review #2:“We used to inject the dog with Hexadog, but the veterinarian suggested trying Eurikan from the same manufacturer. What can I say, I didn’t pick up any infection for the whole year after the vaccination (they took the “DHPPI2-LR” injection). So I have no doubt about its effectiveness. True, there was a big bump at the injection site for about 4 days, but then it went away on its own”;

Review #3:“I heard a lot of rave reviews about Eurican from friends who have dogs. I decided to try making one for my Max. I can’t blame this drug, because my comrades praise it; their dogs had no side effects. But the vaccine is definitely not suitable for Max: he refused to go for a walk (walked in a circle around the house and wandered to the entrance), his nose was dry for a day, he ate very little. The dog was visually unwell. So it’s an individual matter – it suits one person, not another.”

Cost of Eurikan vaccines for dogs

The price for Eurikan drugs is as follows (price for 1 dose):

• "DHPPI2-L" - 270-350 rubles.
• "DHPPI2-LR" - 450-550 rubles.
• “Piro” - 2300-3000 rubles.
• “Primo” - 250-300 rubles.

It's no secret that four-legged pets get sick no less often than their owners. Unfortunately, ailments of dogs and cats in most cases turn out to be quite serious. In order to save a friend, you must act quickly and calmly. Let's figure out why the Eurican vaccine is needed, what effect it has, and what diseases it is aimed at treating.

"Eurikan": description

"Eurikan" is a complex hexavalent vaccine. The composition of the drug is two-component. It includes:

• "Eurikan" DHPPI2 is a lyophilized vaccine aimed at combating canine distemper, parvovirus, adenovirus, as well as type 2 parainfluenza in dogs.
• "Eurikan" RL - liquid vaccine. Contains in inactivated form, as well as leptospira of the Canicola and Interohemorrhagia serogroups.

Another type of vaccine is also commercially available. Its composition contains “Eurikan” L instead of “Eurikan” RL. The difference between this liquid component and the one mentioned earlier is that it does not contain an inactivated rabies virus. Consequently, when vaccinated with such a drug, the dog does not acquire immunity from this dangerous disease.

Indications for use of the vaccine

For what diseases is Eurican used? Instructions for use reveal the purpose of the drug:

1. Carnivore distemper is a viral disease that manifests itself in extensive damage to the dog’s skin in combination with fever, damage to the nervous system and gastrointestinal tract. In addition, the course of the disease is often complicated by pneumonia. Puppies are especially susceptible to canine distemper, but infection in adulthood cannot be ruled out.
2. Adenoviral infection is a contagious disease that affects the larynx, bronchi and trachea. Signs of the disease include cough, nasal discharge, fever, vomiting, as well as intestinal and stomach disorders. Symptoms such as shortness of breath and decreased activity of the dog are also common.
3. Parvovirus infection has two forms of manifestation: intestinal and cardiac. Symptoms of the first type are fever, diarrhea, vomiting, inflammation of the mucous membranes, and abdominal pain. In the cardiac form of infection, damage to the heart muscles occurs.
4. Parainfluenza type 2 - affects the upper respiratory tract. Manifests itself in the form of tonsillitis, cough, serous discharge from the nose. Vomiting is sometimes observed. At the same time, the dog’s appetite does not deteriorate.
5. Leptospirosis is an infectious disease that poses a danger not only to the pet, but also to its owner. It proceeds secretly. Does not show any clinical signs. The pathogen, entering the dog’s body, causes damage to the liver, kidneys and mucous membranes, fever, jaundice, and dysfunction of the central nervous system. The incubation period does not exceed 15 days. Leptospirosis leads to the inevitable death of the animal.

Contraindications and side effects

Contraindications to the use of the vaccine in animals are: the following factors:

• Do not use in already infected dogs.
• Helminth infestation. If deworming is used, vaccination is recommended no earlier than 10 days after the procedure.

Like any other drug, Eurikan also has some side effects. Instructions for use for dogs warn of possible swelling at the injection site. In rare cases, an allergic reaction cannot be ruled out, requiring subsequent symptomatic treatment. "Eurican" activates the production of antibodies specific to the previously mentioned viruses. The pet’s immunity is formed already on the 21st day after vaccination. And the protective effect lasts throughout the year.

"Eurikan": instructions for use, manufacturer

The medicine is produced in France by the pharmaceutical company Merial. Before vaccination, a mixture must be prepared from the two components that make up the drug. In this case, it is necessary to follow the rules of antiseptics and use only sterile materials. The injection dose, regardless of the weight and age of the animal, is 1 ml. It is recommended to carry out the first vaccination at the 7th week of a dog’s life, and repeat vaccination after three to five weeks.

"Eurikan" for puppies: instructions for use

One of the main issues is the possibility of using the vaccine for puppies. After all, most viral infections occur in childhood. So, is Eurikan safe in this case? Instructions for use allow vaccination of animals from 3 months. The drug is safe and easily tolerated by the puppy without causing side effects.

In addition, the vaccine can be used even in pregnant females. Neither abortions, nor a decrease in litter size, nor other local or systemic reactions are observed in the bitches. The main condition is sterility in the preparation of the solution, as well as the health of the animal. If there are symptoms of infection, the vaccine can worsen the situation and lead to the inevitable death of the dog. Pay attention to the health of your pets and prevent dangerous diseases in a timely manner.